| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 4, 2025 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 16.3 | -35,770 | -46.88% | ✗ | $7.4M |
| Feb 20, 2025 | Feb 24, 2025 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 10.0 | -5,778 | -20.52% | ✓ | $1.1M |
| Feb 28, 2024 | Mar 1, 2024 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 5.0 | -17,776 | -63.10% | ✓ | $3.2M |
| Feb 23, 2024 | Feb 27, 2024 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 5.0 | -13,753 | -32.80% | ✓ | $2.4M |
| Feb 2, 2024 | Feb 6, 2024 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 51.3 | - | 0.00% | ✓ | $496.2K |
| Apr 3, 2023 | Apr 5, 2023 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 7.5 | -3,520 | -25.33% | ✓ | $563.2K |
| Feb 28, 2023 | Mar 2, 2023 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 5.0 | -21,791 | -67.74% | ✓ | $3.3M |
| Feb 21, 2023 | Feb 22, 2023 | AbbVie Inc. | EVP, GC AND SECRETARY | Sell | 15.0 | -7,364 | -18.63% | ✓ | $1.1M |